Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

13.43

-0.77 (-5.42%)

At close: May 18, 2026, 4:00 PM EDT

13.24

-0.19 (-1.41%)

Pre-market: May 19, 2026, 7:00 AM EDT

Trevi Therapeutics Employees

Trevi Therapeutics had 34 employees as of December 31, 2025. The number of employees increased by 8 or 30.77% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

30.77%

Revenue / Employee

n/a

Profits / Employee

-$1,341,500

Market Cap

1.91B

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	34	8	30.77%
Dec 31, 2024	26	1	4.00%
Dec 31, 2023	25	0	-
Dec 31, 2022	25	1	4.17%
Dec 31, 2021	24	2	9.09%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Sarepta Therapeutics	835
ADMA Biologics	647
Ascentage Pharma Group International	605
Lakefront Biotherapeutics NV	558
Ocular Therapeutix	325
Zymeworks	243
Stoke Therapeutics	170
Pharvaris	129